News Rapid COVID immune status test launched in UK, Ireland You've had your two COVID-19 jabs, but are you actually protected against infection?
News ASCO: TIGIT returns with Roche, Gilead data A year ago, enthusiasm for a new generation of cancer immunotherapies targeting TIGIT started to wane, after Roche’s tiragolumab was hit by two
Spotlight on Spotlight on the World Without Disease Summit Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas
